NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 212 filers reported holding NOVAVAX INC in Q2 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,343,627 | +103.3% | 461,827 | +108.7% | 0.01% | +125.0% |
| Q2 2023 | $1,644,356 | +197.8% | 221,313 | +177.8% | 0.00% | +300.0% |
| Q1 2023 | $552,134 | +176.2% | 79,673 | +309.7% | 0.00% | 0.0% |
| Q4 2022 | $199,936 | +156.3% | 19,449 | +355.9% | 0.00% | – |
| Q3 2022 | $78,000 | -73.5% | 4,266 | -25.3% | 0.00% | -100.0% |
| Q2 2022 | $294,000 | -87.7% | 5,712 | -82.4% | 0.00% | -80.0% |
| Q1 2022 | $2,385,000 | +279.8% | 32,389 | +835.8% | 0.01% | +400.0% |
| Q1 2021 | $628,000 | -75.4% | 3,461 | -85.3% | 0.00% | -83.3% |
| Q3 2020 | $2,548,000 | -60.0% | 23,519 | -69.2% | 0.01% | -62.5% |
| Q2 2020 | $6,366,000 | +1545.0% | 76,379 | +167.8% | 0.02% | +1500.0% |
| Q1 2020 | $387,000 | +74.3% | 28,520 | -48.9% | 0.00% | – |
| Q4 2019 | $222,000 | +181.0% | 55,836 | +253.8% | 0.00% | – |
| Q3 2019 | $79,000 | -7.1% | 15,784 | +8.6% | 0.00% | – |
| Q2 2019 | $85,000 | – | 14,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HELLMAN JORDAN MANAGEMENT CO INC /MA/ | 50,910 | $5,516,000 | 10.50% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 297,400 | $32,223,000 | 4.94% |
| Ikarian Capital, LLC | 375,400 | $40,675,000 | 2.94% |
| TSP Capital Management Group, LLC | 60,075 | $6,509,000 | 2.66% |
| RA Capital Management | 1,198,602 | $129,869,000 | 2.38% |
| Foresite Capital Management I, LLC | 66,810 | $7,239,000 | 2.04% |
| Healthcare Value Capital, LLC | 5,000 | $542,000 | 1.79% |
| Rock Springs Capital Management LP | 585,705 | $63,461,000 | 1.61% |
| Foresite Capital Management II, LLC | 67,373 | $7,300,000 | 1.59% |
| BERYLSON CAPITAL PARTNERS, LLC | 30,104 | $3,262,000 | 1.14% |